Keyphrases
Dendritic Cells
100%
Treg
100%
Radiation Therapy
100%
Head-and-neck Squamous Cell Carcinoma (HNSCC)
100%
Human Genes
28%
Gene Set
28%
Lymph Node
28%
Treg Depletion
28%
Agonism
28%
Anti-CD137
28%
Radioresistant Tumors
28%
Tumor Necrosis Factor-α
14%
Treatment Group
14%
Interferon-α (IFN-α)
14%
RNA Sequencing (RNA-seq)
14%
Tumor
14%
Tumor Growth
14%
Phosphoinositide 3-kinase (PI3K)
14%
T Cells
14%
Batf3
14%
Tumor-draining Lymph Nodes
14%
CD103+ Dendritic Cells
14%
Therapeutic Approaches
14%
CD8+ T Cells
14%
New Therapeutics
14%
Therapeutic Potential
14%
Tumor Microenvironment
14%
Radioimmunotherapy
14%
Transfer Research
14%
Immune Checkpoint Inhibitors
14%
Adoptive Transfer
14%
Orthotopic Tumor
14%
Genetically Engineered Mouse Models
14%
Cytotoxic T-lymphocyte antigen-4 (CTLA-4)
14%
Microenvironment
14%
AKT1
14%
In Vitro Experiment
14%
Oral Tongue Squamous Cell Carcinoma (OTSCC)
14%
Response to Radiation
14%
Effector Responses
14%
Antigen-specific T Cell Response
14%
CD80
14%
Orthotopic Model
14%
Therapeutic Benefits
14%
CD25+
14%
Dendritic Cell Activation
14%
Hypofractionation
14%
HPV Negative
14%
Early Recurrence
14%
Neuropilin-1 (NRP-1)
14%
CD137
14%
Eomes
14%
Regulatory T Cell(Treg)
14%
Activation Status
14%
CCR7
14%
MOC2
14%
Tumor Eradication
14%
DEREG
14%
Cold Model
14%
Medicine and Dentistry
Dendritic Cell
100%
Immunotherapy
100%
Radiation Therapy
100%
Tumor
57%
Lymph Node
42%
Head and Neck Squamous Cell Carcinoma
42%
CD137
42%
Cell Activation
28%
Neoplasm
28%
Tumor Necrosis Factor
14%
Interferon
14%
In Vitro
14%
RNA Sequencing
14%
T Cell
14%
Immunosuppressive Drug
14%
Recurrent Disease
14%
Cytotoxic T-Cell
14%
Cytometry
14%
Immune Checkpoint Inhibitor
14%
Tumor Progression
14%
Adoptive Transfer Study
14%
Tumor Microenvironment
14%
Radioimmunotherapy
14%
Mouth Squamous Cell Carcinoma
14%
Regulatory T Cell
14%
Treatment Group
14%
Pharmacology, Toxicology and Pharmaceutical Science
Immunotherapy
100%
Head and Neck Squamous Cell Carcinoma
100%
Neoplasm
66%
Mouse Model
66%
Tumor Necrosis Factor
33%
Tumor Growth
33%
Interferon
33%
CD8 Antigen
33%
Immunosuppressive Agent
33%
Recurrent Disease
33%
Genetically Engineered Mouse Strain
33%
Tumor Microenvironment
33%
Mouth Squamous Cell Carcinoma
33%
Immune Checkpoint Inhibitor
33%
Cytotoxic T Lymphocyte Antigen 4
33%
Treatment Group
33%
Immunology and Microbiology
Dendritic Cell
100%
Regulatory T Cell
100%
Immunotherapy
100%
Squamous Cell
40%
Lymph Node
30%
Neck
30%
Cell Activation
20%
Mouse Model
20%
interferon
10%
T Cell
10%
Tumor Necrosis Factor
10%
Immunosuppressive Drug
10%
Cytotoxic T-Cell
10%
Adoptive Transfer Study
10%
Effector Cell
10%
RNA Sequencing
10%
Genetically Engineered Mouse Strain
10%
CD80
10%
CD25
10%
In Vitro
10%
Immune Checkpoint Inhibitor
10%